FGFR2 and nasopharyngeal carcinoma: For example, in nasopharyngeal carcinoma, CAFs secrete high levels of fibroblast growth factor 5 (FGF5), which binds to fibroblast growth factor receptor 2 (FGFR2) in tumor cells, hence inhibiting cisplatin-induced ferroptosis [38].